ChiCTR-INR-16009598
正在进行
/
/
/
2016-10-25
/
/
冠心病
基于智能手机的家庭心脏康复和冠心病患者二级预防的随机对照研究
基于智能手机的家庭心脏康复和冠心病患者二级预防的随机对照研究
The aim of the clinical trial is to assess the effects of smartphone-based cardiac rehabilitation and secondary prevention program on the short-term and long-term outcomes of post-PCI CHD patients, as well as its effects on improvement of quality of life, enhancing management of risk factors and medication, increasing cost benefits and reducing hospital readmissions.
随机平行对照
治疗新技术
The Project Manager will be supplied with one randomization envelope for each participant. It is the responsibility of the Project Manager to ensure that these randomization envelopes are safely stored, but readily available to the relevant staff. Once patients have signed the Consent Form, they will provided with a
/
Curtin University PhD research funding
/
300
/
2016-05-06
2019-05-05
/
Eligible participants will be patients diagnosed with coronary heart disease and received PCI. Inclusion criteria are that the participant must: Diagnosed by a clinician, have met criteria for diagnosis of CHD; Received PCI therapy during this admission; Aged between 18-70 years; Have an active smartphone, and have sufficient Chinese language proficiency to reading, speaking and listening; Able to operate smartphone for the purposes of trial; Living with at least one caregiver or guardian in the household; Presence of normal hemodynamics with a resting ejection fraction ≥ 50%; Able to individually consent; Not participating in any other clinical trial.;
请登录查看Unable to be involved in clinical follow up and treatment; Unable to operate smartphone for the purpose of the trial (eg, vision, hearing, cognitive or dexterity impairment); Had no experience with WeChat application; Have no internet connection at residence and smartphone Wi-Fi connection; Have contra-indication to CR.;
请登录查看Curtin University
/
Curtin University的其他临床试验
Curtin University的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
Curtin University相关推荐
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构:国家医保局 2026-07-31
-
颁布机构:国家药品审评中心(CDE) 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构:国家市场监督管理总局 2026-08-10
-
颁布机构:国家市场监督管理总局 2026-05-29
-
颁布机构:国家市场监督管理总局 2026-05-29
